Skip to main content

Vera Therapeutics, Inc.

VERA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001831828

In the last 90 days, Vera Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 219 institutions reported holding it in 13F filings for Q2 2026, worth $3.34B in total; no superinvestor holds it.

13F holders, Q1 2023

Institutional positions in Vera Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
70
+12 vs. Q4 2022
Shares held
37.4M
+19.0M (+103.3%) vs. Q4 2022
Total value
$289.7M
−$65.7M (−18.5%) vs. Q4 2022
New holders
22
29 more added
Sold out
10
10 more reduced

1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting VERA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2023: 70 institutions
Q1 2021: 0 institutionsQ2 2021: 22 institutionsQ3 2021: 31 institutionsQ4 2021: 37 institutionsQ1 2022: 50 institutionsQ2 2022: 51 institutionsQ3 2022: 55 institutionsQ4 2022: 59 institutionsQ1 2023: 70 institutionsQ2 2023: 76 institutionsQ3 2023: 84 institutionsQ4 2023: 95 institutionsQ1 2024: 159 institutionsQ2 2024: 171 institutionsQ3 2024: 173 institutionsQ4 2024: 178 institutionsQ1 2025: 179 institutionsQ2 2025: 172 institutionsQ3 2025: 176 institutionsQ4 2025: 214 institutionsQ1 2026: 229 institutionsQ2 2026: 219 institutions
Value heldQ1 2023: $289.7M
Q1 2021: $0Q2 2021: $186.1MQ3 2021: $252.4MQ4 2021: $374.9MQ1 2022: $468.9MQ2 2022: $277.6MQ3 2022: $459.0MQ4 2022: $412.8MQ1 2023: $289.7MQ2 2023: $611.9MQ3 2023: $538.2MQ4 2023: $637.2MQ1 2024: $2.21BQ2 2024: $1.92BQ3 2024: $2.37BQ4 2024: $2.66BQ1 2025: $1.52BQ2 2025: $1.51BQ3 2025: $1.89BQ4 2025: $3.75BQ1 2026: $2.92BQ2 2026: $3.34B
Institutions holding VERA and their total value by quarter
QuarterHoldersValue
Q2 2026219$3.34B
Q1 2026229$2.92B
Q4 2025214$3.75B
Q3 2025176$1.89B
Q2 2025172$1.51B
Q1 2025179$1.52B
Q4 2024178$2.66B
Q3 2024173$2.37B
Q2 2024171$1.92B
Q1 2024159$2.21B
Q4 202395$637.2M
Q3 202384$538.2M
Q2 202376$611.9M
Q1 202370$289.7M
Q4 202259$412.8M
Q3 202255$459.0M
Q2 202251$277.6M
Q1 202250$468.9M
Q4 202137$374.9M
Q3 202131$252.4M
Q2 202122$186.1M
Q1 20210$0

Institutions, Q1 2023

Shares, value and share of portfolio for each institution holding Vera Therapeutics, Inc.; share changes are against Q4 2022.

Institutions holding VERA in Q1 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Nisa Investment Advisors, LLC11$00.00%−6−35.3%Reduced
Ameritas Investment Partners, Inc.1,061$8.23K0.00%00.0%Unchanged
Metropolitan Life Insurance Co1,328$10.3K0.00%+287+27.6%Added
Royal Bank of Canada1,714$13.0K0.00%−819−32.3%Reduced
Amalgamated Bank2,595$20.0K0.00%+392+17.8%Added
Legal & General Group Plc2,579$20.0K0.00%−3,327−56.3%Reduced
Wells Fargo & Company4,207$32.6K0.00%+4,207New
Tower Research Capital LLC (TRC)4,834$38.0K0.00%+4,303+810.4%Added
California State Teachers Retirement System8,070$62.6K0.00%−10,627−56.8%Reduced
MetLife Investment Management8,881$68.9K0.00%00.0%Unchanged
UBS Group AG8,933$69.3K0.00%+8,036+895.9%Added
Simplex Trading, LLC9,492$73.0K0.00%+9,492New
Cambridge Trust Co9,887$76.7K0.00%00.0%Unchanged
Sandia Investment Management LP10,000$77.6K0.01%+10,000New
Walleye Capital LLC10,100$78.4K0.00%−219,104−95.6%Reduced
Virtu Financial LLC10,481$81.0K0.01%+10,481New
American International Group, Inc.10,476$81.3K0.00%+3,698+54.6%Added
Barclays PLC10,972$85.1K0.00%−2,307−17.4%Reduced
New York State Common Retirement Fund11,013$85.5K0.00%00.0%Unchanged
XTX Topco Ltd11,815$91.7K0.02%+11,815New
Deutsche Bank AG13,950$108.3K0.00%+7,602+119.8%Added
SG Americas Securities, LLC14,384$112.0K0.00%+14,384New
Carnegie Mellon University16,060$124.6K0.08%00.0%Unchanged
Gsa Capital Partners LLP16,272$126.0K0.01%+16,272New
JPMorgan Chase & Co16,642$129.0K0.00%−97,340−85.4%Reduced
Ensign Peak Advisors, Inc17,816$138.3K0.00%00.0%Unchanged
Raymond James Financial Services Advisors, Inc.17,828$138.3K0.00%00.0%Unchanged
Jane Street Group, LLC19,299$149.8K0.00%+19,299New
Raymond James & Associates25,285$196.2K0.00%+25,285New
Rhumbline Advisers27,294$212.0K0.00%+9,241+51.2%Added
Alps Advisors Inc27,629$214.4K0.00%+8,880+47.4%Added
Susquehanna International Group, LLP29,350$227.8K0.00%+29,350New
Crestline Management, LP29,367$227.9K0.03%+29,367New
Morgan Stanley40,668$315.6K0.00%+25,115+161.5%Added
Marshall Wace, LLP44,786$347.5K0.00%+44,786New
Two Sigma Investments, LP47,014$364.8K0.00%+29,997+176.3%Added
Jump Financial, LLC52,700$409.0K0.02%+35,100+199.4%Added
Charles Schwab Investment Management Inc61,419$476.6K0.00%+22,560+58.1%Added
Squarepoint Ops LLC66,116$513.1K0.00%+66,116New
Nuveen Asset Management, LLC78,939$612.0K0.00%−19,197−19.6%Reduced
State of Wisconsin Investment Board84,000$651.8K0.00%+69,844+493.4%Added
Bank of America Corp87,837$681.6K0.00%+36,161+70.0%Added
Bank of New York Mellon Corp97,980$760.3K0.00%+26,210+36.5%Added
Cubist Systematic Strategies, LLC159,914$1.24M0.01%+159,914New
Renaissance Technologies LLC174,800$1.36M0.00%+149,900+602.0%Added
Northern Trust Corp193,385$1.50M0.00%+67,904+54.1%Added
UBS Oconnor LLC223,468$1.73M0.04%+223,468New
Altium Capital Management LP286,000$2.22M1.33%+286,000New
Polar Asset Management Partners Inc.300,000$2.33M0.04%−114,000−27.5%Reduced
Alphabet Inc.301,580$2.34M0.13%00.0%Unchanged
State Street Corp304,147$2.36M0.00%+47,451+18.5%Added
Baker Bros. Advisors LP333,333$2.59M0.01%00.0%Unchanged
Geode Capital Management, LLC480,045$3.73M0.00%+222,979+86.7%Added
Sectoral Asset Management Inc600,300$4.66M0.90%+600,300New
Citadel Advisors LLC775,792$6.02M0.01%−1,215,681−61.0%Reduced
Octagon Capital Advisors LP795,000$6.17M0.89%+129,844+19.5%Added
International Biotechnology Trust PLC1,002,257$7.75M2.16%+721,000+256.3%Added
Point72 Asset Management, L.P.1,037,128$8.05M0.03%+1,037,128New
Deerfield Management Company, L.P. (Series C)1,300,000$10.1M0.22%+1,300,000New
OrbiMed Advisors LLC1,362,400$10.6M0.21%+1,362,400New
Vanguard Group Inc1,394,851$10.8M0.00%+627,318+81.7%Added
BlackRock Inc.1,410,270$10.9M0.00%+534,386+61.0%Added
Woodline Partners LP1,752,718$13.6M0.19%+1,603,165+1,072.0%Added
Eversept Partners, LP1,788,529$13.9M1.25%+1,377,221+334.8%Added
Millennium Management LLC1,887,351$14.6M0.02%+778,702+70.2%Added
Commodore Capital LP2,824,029$21.9M3.34%+2,824,029New
Carlyle Group Inc.2,960,231$22.9M0.68%+2,960,231New
Kynam Capital Management, LP3,372,428$26.2M3.39%+1,963,330+139.3%Added
Sofinnova Investments, Inc.3,467,156$26.9M1.82%+285,714+9.0%Added
FMR LLC5,796,259$45.0M0.00%+1,647,613+39.7%Added
Vivo Capital, LLC0$00.00%−400,666−100.0%Sold out
Logos Global Management LP0$00.00%−285,000−100.0%Sold out
Swiss National Bank0$00.00%−35,900−100.0%Sold out
Pura Vida Investments, LLC0$00.00%−35,372−100.0%Sold out
Moore Capital Management, LP0$00.00%−25,000−100.0%Sold out
Dimensional Fund Advisors LP0$00.00%−11,498−100.0%Sold out
Walleye Trading LLC0$00.00%−10,945−100.0%Sold out
Credit Suisse AG0$00.00%−9,558−100.0%Sold out
Gyon Technologies Capital Management, LP0$00.00%−9,413−100.0%Sold out
Citigroup Inc0$00.00%−467−100.0%Sold out
Abingworth LLP––––Not filed